title: Comment on Ågren et al. Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes. Diabetes care 2014;37:2007-2014.
authors.affiliation: Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands d.rijken@erasmusmc.nl.
authors.forename: Dingeman C
authors.initials: DC
authors.lastname: Rijken
authors.affiliation: Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.
authors.forename: Shirley
authors.initials: S
authors.lastname: Uitte de Willige
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D005260:Female; D005337:Fibrin / Q000378:metabolism*; D006801:Humans; D008297:Male; D000979:alpha-2-Antiplasmin / Q000378:metabolism*
chemical_list: D000979:alpha-2-Antiplasmin; D005337:Fibrin